| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |